Back to funds

Euclidean Capital LLC

Updated 6 days ago

Managed by Euclidean Capital Llc • Latest filing Q3 2026

Portfolio value
$323.6M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$369.5M
Q1 2026$392.3M
Q2 2026$439.8M
Q3 2026$323.6M

Top holdings

10 positions as of Q3 2026

View filing
V

VANGUARD INTL EQUITY INDEX F

Value
$269.1M
Shares
3.24M
% Port
83.15%
E

ISHARES TR

Value
$17.3M
Shares
369.6K
% Port
5.33%
O

ORIC PHARMACEUTICALS INC

Value
$13.3M
Shares
989.4K
% Port
4.12%
T

TEAMSHARES INC

Value
$8M
Shares
1.10M
% Port
2.47%
F

FOGHORN THERAPEUTICS INC

Value
$5.6M
Shares
1.57M
% Port
1.74%
P

PMV PHARMACEUTICALS INC

Value
$4.4M
Shares
2.63M
% Port
1.36%
S

SURROZEN INC

Value
$2.8M
Shares
87.7K
% Port
0.87%
A

ALECTOR INC

Value
$2.4M
Shares
1.31M
% Port
0.75%
T

TENAYA THERAPEUTICS INC

Value
$613K
Shares
1.02M
% Port
0.19%
?
10.N/A

MERLIN INC

Value
$90K
Shares
47.6K
% Port
0.03%

Explore